Sabrina serves as Director of Research and Development at T-CURX, bringing over nine years of pharmaceutical industry expertise in R&D to the T-CURX' leadership team. In her role, Sabrina leads the internal CAR-T R&D efforts, spearheading discovery, pre-IND, and translational activities.

Throughout her career, Sabrina has focused on developing innovative immunotherapeutics for cancer patients, maintaining a proven track record of driving candidates from pre-IND stage into clinical development. She is a seasoned scientific and people leader, who previously held R&D leadership roles at MorphoSys in Munich and Bristol-Myers Squibb in the San Francisco Bay Area, U.S. As a trained cellular immunologist, Sabrina possesses a deep understanding of mode of action of immunotherapies, with a particular focus on myeloid-T cell cross-talk within the tumor microenvironment.